No Data
No Data
12 Health Care Stocks Moving In Friday's Intraday Session
Psyence Biomedical Faces Nasdaq Delisting Amid Shareholder Approval for Reverse Stock Split
Psyence BioMed Gets Nasdaq Notice for Non-compliance
Express News | Psyence Group Inc - to Consolidate Shares 15 to 1 Effective April 23, 2025
'Psyence BioMed Announces $500,000 Follow-On Investment In PsyLabs And Global Ibogaine Supply Agreement' - BioSpace
Psyence Biomedical Transitions CRO for Psilocybin Trial in April 2025